Response Biomedical Corp - Company Profile
Powered by 
All the sales intelligence you need on Response Biomedical Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Response Biomedical Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Response Biomedical Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Response Biomedical Corp (Response Biomedical), a subsidiary of Shanghai Runda Medical and Technology Co Ltd, researches, develops, manufactures and markets acute care diagnostic testing cards through its RAMP platform in cardiovascular, infectious disease, sepsis, women’s health, arbovirus, and biodefense. Its products include test kits for D-dimer; proBNP; Troponin I; Myoglobin; CK-MB TestCOVID-19 Antigen; FLU A+B; RSV infection; Procalcitonin; TOTAL B-hCG; arbovirus including WNV, Degue, and Zika; and biodefense. It also offers controls for Procalcitonin; Cardiac; and TOTAL B-hCG. The company offers point-of-care instruments. The company distributes products through a network of distributors worldwide. Response Biomedical is headquartered in Vancouver, British Columbia, Canada.
Response Biomedical Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Cardiovascular Tests: | RAMP |
| D-dimer | |
| NT-proBNP | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Response Biomedical Corp | Becton Dickinson and Co | Abbott Point of Care Inc | Alere Inc | Alexeter Technologies LLC |
|---|---|---|---|---|---|
| Headquarters | Canada | United States of America | United States of America | United States of America | United States of America |
| City | Vancouver | Franklin Lakes | Princeton | Waltham | Wheeling |
| State/Province | British Columbia | New Jersey | New Jersey | Massachusetts | Illinois |
| No. of Employees | - | 72,000 | - | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Taso Tsonis | Chief Financial Officer; Interim Chief Executive Officer | Senior Management | 2025 | - |
| Angela Carter | Vice President - Global Channel Strategy | Senior Management | - | - |
| Ellen Green | Senior Director - Quality, Regulatory, and Clinical | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer